Sweden’s Affibody Inks Inmagene China R&D Pact

Affibody And Inmagene Will Focus On Auto-Immune Diseases

China_Sweden_Coins
Duo aim to commercialize ABY-035 targeting IL-17 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business